Evaluation of efficacy of intra articular injection of mannitol versus hypertonic dextrose prolotherapy on decreasing pain and improvement of functions in patients with knee osteoarthritis
Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
Evaluation of efficacy of intra articular injection of monitol versus hypertonic dextrose porlothrapy on decreasing pain and improvement of function in patients with knee osteoarthritis randomize clinical trial
Evaluation of efficacy of intra articular injection of mannitol versus hypertonic dextrose prolothrapy on decreasing pain and improvement of function in patients with knee osteoarthritis randomize clinical trial
Evaluation of efficacy of intra articular injection of monitolmannitol versus hypertonic dextrose porlothrapyprolothrapy on decreasing pain and improvement of function in patients with knee osteoarthritis randomize clinical trial
Intervention group:group that receive knee intra articular injection of monitol
control group: group that receive knee intra articular injection of hypertonic Dextrose.
Intervention group:group that receive knee intra articular injection of mannitol
control group: group that receive knee intra articular injection of hypertonic Dextrose.
Intervention group:group that receive knee intra articular injection of monitolmannitol control group: group that receive knee intra articular injection of hypertonic Dextrose.
General information
Triple blinded
Double blinded
tripldoubl
empty
misspelling
misspelling
empty
غلط املایی
غلط املایی
Evaluation of efficacy of intra articular injection of monitol in patient with knee osteoarthritis
Evaluation of efficacy of intra articular injection of mannitol in patient with knee osteoarthritis
Evaluation of efficacy of intra articular injection of monitolmannitol in patient with knee osteoarthritis
Evaluation of efficacy of intra articular injection of monitor versus hypertonic dextrose porlothrapy on decreasing pain and improvement of functions in patients with knee osteoarthritis
Evaluation of efficacy of intra articular injection of mannitol versus hypertonic dextrose prolotherapy on decreasing pain and improvement of functions in patients with knee osteoarthritis
Evaluation of efficacy of intra articular injection of monitormannitol versus hypertonic dextrose porlothrapyprolotherapy on decreasing pain and improvement of functions in patients with knee osteoarthritis
Participant: The participant is explained that if they are interested, they can join our research project. two methods used to reduce patient pain input study are explained to the patient. Benefits and possible complications of both methods are described to the patient and the patient is told to randomly fall into one of the intervention groups. If the patient is accepted to admit the study, by random allocation soft ware, the patient falls in to one of two groups.
Clinical car giver: we teach the caregiver how to complete the questionnaier. This person is not aware of receiving patient intervention.
Researcher: In this study does not have the ability to blind the reseacher because the researcher performs both intervention himself and is aware of receiving each intervention in the group.
The outcome assessor of the complete questionnaires is given to person who is not aware of the interventions performed and he/she is asked to determine the level of performance in each person according to the questionnaires.
Date analyzer: questionnaire are finally given to a person to review the information. This person doesn't know any of the steps of the work, how to classify and the intervention performed.
Participant: The participant is explained that if they are interested, they can
join our research project. two methods used to reduce patient pain input study are explained to the patient. Benefits and possible complications of both methods are described to the patient and the patient is told to randomly fall into one of the intervention groups. If the patient is accepted to admit the study, by random allocation soft ware, the patient falls in to one of two groups.
Clinical car giver: we teach the caregiver how to complete the questionnaier. This person is not aware of receiving patient intervention.
Researcher: In this study does not have the ability to blind the reseacher because the researcher performs both intervention himself and is aware of receiving each intervention in the group.
The outcome assessor of the complete questionnaires is given to person who is not aware of the interventions performed and he/she is asked to determine the level of performance in each person according to the questionnaires.
Date analyzer: questionnaire are finally given to a person to review the information. This person doesn't know any of the steps of the work, how to classify and the intervention performed.
Participant: The participant is explained that if they are interested, they can join our research project. two methods used to reduce patient pain input study are explained to the patient. Benefits and possible complications of both methods are described to the patient and the patient is told to randomly fall into one of the intervention groups. If the patient is accepted to admit the study, by random allocation soft ware, the patient falls in to one of two groups. Clinical car giver: we teach the caregiver how to complete the questionnaier. This person is not aware of receiving patient intervention. Researcher: In this study does not have the ability to blind the reseacher because the researcher performs both intervention himself and is aware of receiving each intervention in the group. The outcome assessor of the complete questionnaires is given to person who is not aware of the interventions performed and he/she is asked to determine the level of performance in each person according to the questionnaires. Date analyzer: questionnaire are finally given to a person to review the information. This person doesn't know any of the steps of the work, how to classify and the intervention performed.
شرکت کننده: به شرکت کننده توضیح داده میشود که در صورت علاقه مندی میتواند وارد طرح تحقیقاتی ما شود.دو روشی که جهت کاهش درد بیمار در مطالعه ما به کار گرفته میشوند برای بیمار توضیح داده میشود.فواید و عوارض احتمالی هر دو روش برای بیمار شرح میشودوبه بیمار گفته میشود که به صورت اتفاقی در یکی از گروه های مداخله قرار میگیرد.در صورت قبول بیمار برای ورود به مطالعهبه روش random allocation soft ware بیمار در یکی از دو گروه قرار میگیرد.
مراقب بالینی: به فردی که مراقبت و پیگیری بیماران را به عهده دارد نحوه تکمیل پرسشنامه را اموزش میدهیم این فرد از مداخله بیمار اطلاعی ندارد
محقق:در این مطالعه توانایی کور سازی محقق را نداریم چون محقق. هر دو مطالعه را خودش انجام میدهد و از دریافت هر مداخله ای در هر گروه اطلاع دارد.
ارزیابی کننده پیامد: پرسشنامه های تکمیل شده به فردی که از مداخلات انجام شده اطلاعی ندارد سپرده میشود و از او خواسته میشود که میزان کاهش درد و افزایشعملکرد در هر فرد را با توجه به پرسشنامه تعیین کند
انالیز کننده داده ها: پرسشنامه ها در نهایت پس از تکمیل و جمع اوری کلیه اطلاعات به فردی جهت بررسی اطلاعات داده میشود این فرد از هیچ یک از مراحل انجام کار و نحوه تقسیم بندی مداخله انجام شده اطلاعی ندارد.
شرکت کننده: به شرکت کننده توضیح داده میشود که در صورت علاقه مندی میتواند وارد طرح تحقیقاتی ما شود.دو روشی که جهت کاهش درد بیمار در مطالعه ما به کار گرفته میشوند برای بیمار توضیح داده میشود.فواید و عوارض احتمالی هر دو روش برای بیمار شرح میشودوبه بیمار گفته میشود که به صورت اتفاقی در یکی از گروه های مداخله قرار میگیرد.در صورت قبول بیمار برای ورود به مطالعهبه روش random allocation soft ware بیمار در یکی از دو گروه قرار میگیرد.
مراقب بالینی: به فردی که مراقبت و پیگیری بیماران را به عهده دارد نحوه تکمیل پرسشنامه را اموزش میدهیم این فرد از مداخله بیمار اطلاعی ندارد
محقق:در این مطالعه توانایی کور سازی محقق را نداریم چون محقق. هر دو مطالعه را خودش انجام میدهد و از دریافت هر مداخله ای در هر گروه اطلاع دارد.
ارزیابی کننده پیامد: پرسشنامه های تکمیل شده به فردی که از مداخلات انجام شده اطلاعی ندارد سپرده میشود و از او خواسته میشود که میزان کاهش درد و افزایشعملکرد در هر فرد را با توجه به پرسشنامه تعیین کند
انالیز کننده داده ها: پرسشنامه ها در نهایت پس از تکمیل و جمع اوری کلیه اطلاعات به فردی جهت بررسی اطلاعات داده میشود این فرد از هیچ یک از مراحل انجام کار و نحوه تقسیم بندی مداخله انجام شده اطلاعی ندارد.
شرکت کننده: به شرکت کننده توضیح داده میشود که در صورت علاقه مندی میتواند وارد طرح تحقیقاتی ما شود.دو روشی که جهت کاهش درد بیمار در مطالعه ما به کار گرفته میشوند برای بیمار توضیح داده میشود.فواید و عوارض احتمالی هر دو روش برای بیمار شرح میشودوبه بیمار گفته میشود که به صورت اتفاقی در یکی از گروه های مداخله قرار میگیرد.در صورت قبول بیمار برای ورود به مطالعهبه روش random allocation soft ware بیمار در یکی از دو گروه قرار میگیرد. مراقب بالینی: به فردی که مراقبت و پیگیری بیماران را به عهده دارد نحوه تکمیل پرسشنامه را اموزش میدهیم این فرد از مداخله بیمار اطلاعی ندارد محقق:در این مطالعه توانایی کور سازی محقق را نداریم چون محقق. هر دو مطالعه را خودش انجام میدهد و از دریافت هر مداخله ای در هر گروه اطلاع دارد. ارزیابی کننده پیامد: پرسشنامه های تکمیل شده به فردی که از مداخلات انجام شده اطلاعی ندارد سپرده میشود و از او خواسته میشود که میزان کاهش درد و افزایشعملکرد در هر فرد را با توجه به پرسشنامه تعیین کند انالیز کننده داده ها: پرسشنامه ها در نهایت پس از تکمیل و جمع اوری کلیه اطلاعات به فردی جهت بررسی اطلاعات داده میشود این فرد از هیچ یک از مراحل انجام کار و نحوه تقسیم بندی مداخله انجام شده اطلاعی ندارد.
Intervention groups
#1
Intervention group: the group that receive 5cc monitol, knee intra articular injection ,in four doses as the first dose and two weeks, four weeks ,eight weeks after first dose and control group that receive 5cc of dextrose 25%,inter articular injection,as sequence of intervention group.
Intervention group: the group that receive 5cc mannitol, knee intra articular injection ,in three doses as the first dose and two weeks, four weeks , weeks after first dose and control group that receive 5cc of dextrose 25%,inter articular injection,as sequence of intervention group.
Intervention group: the group that receive 5cc monitolmannitol, knee intra articular injection ,in fourthree doses as the first dose and two weeks, four weeks ,eight weeks after first dose and control group that receive 5cc of dextrose 25%,inter articular injection,as sequence of intervention group.
گروه مداخله: گروهی که ۵ میلی لیترداروی مانیتول ۷درصد رادر چهار نوبت بصورت نوبت اول ،۲ هفته بعد،۴ هفته بعدو۸ هفته بعد از نوبت اول به صورت داخل مفصلی زانو دریافت کرده اند. و گروه کنترل:گروهی که ۵ میلی لیتر داروی دکستروز ۲۵ درصد را به صورت داخل مفصل زانو با همان توالی زمانی گروه مداخله دریافت میکنند.
گروه مداخله: گروهی که ۵ میلی لیترداروی مانیتول ۷درصد رادر چهار نوبت بصورت نوبت اول ،۲ هفته بعد،۴ هفته بعد از نوبت اول به صورت داخل مفصلی زانو دریافت کرده اند. و گروه کنترل:گروهی که ۵ میلی لیتر داروی دکستروز ۲۵ درصد را به صورت داخل مفصل زانو با همان توالی زمانی گروه مداخله دریافت میکنند.
گروه مداخله: گروهی که ۵ میلی لیترداروی مانیتول ۷درصد رادر چهار نوبت بصورت نوبت اول ،۲ هفته بعد،۴ هفته بعدو۸ هفته بعد از نوبت اول به صورت داخل مفصلی زانو دریافت کرده اند. و گروه کنترل:گروهی که ۵ میلی لیتر داروی دکستروز ۲۵ درصد را به صورت داخل مفصل زانو با همان توالی زمانی گروه مداخله دریافت میکنند.
Recruitment centers
#1
Name of recruitment center - English: Rajaee haspital
Name of recruitment center - Persian: بیمارستان رجایی
Full name of responsible person - English: Amir Reza mesbahi
Full name of responsible person - Persian: امیر رضا مصباحی
Street address - English: chamran Blvd
Street address - Persian: بلوار چمران
City - English: Shiraz
City - Persian: شیراز
Province: Fars
Country: Iran (Islamic Republic of)
Postal code: 7194815711
Phone: +98 71 3636 4001
Fax:
Email: Rajaeehospital@sums.ac.ir
Web page address:
Name of recruitment center - English: Rajaee haspital
Name of recruitment center - Persian: بیمارستان رجایی
Full name of responsible person - English: Amir Reza mesbahi
Full name of responsible person - Persian: امیر رضا مصباحی
Street address - English: Chamran Blvd
Street address - Persian: بلوار چمران
City - English: Shiraz
City - Persian: شیراز
Province: Fars
Country: Iran (Islamic Republic of)
Postal code: 7194815711
Phone: +98 71 3636 4001
Fax:
Email: Rajaeehospital@sums.ac.ir
Web page address:
Name of recruitment center - English: Rajaee haspital Name of recruitment center - Persian: بیمارستان رجایی Full name of responsible person - English: Amir Reza mesbahi Full name of responsible person - Persian: امیر رضا مصباحی Street address - English: chamranChamran Blvd Street address - Persian: بلوار چمران City - English: Shiraz City - Persian: شیراز Province: Fars Country: Iran (Islamic Republic of) Postal code: 7194815711 Phone: +98 71 3636 4001 Fax: Email: Rajaeehospital@sums.ac.ir Web page address:
Protocol summary
Study aim
Evaluation of efficacy of intra articular injection of mannitol versus hypertonic dextrose prolothrapy on decreasing pain and improvement of function in patients with knee osteoarthritis randomize clinical trial
Design
The research is a randomize triple blind clinical trial
Settings and conduct
The patient select from emam reza clinic and rajaee hospital who has knee osteoarthritis.then patient divided into two groups and after obtaining written consent the study begins. in control group hypertonic dextrose is injected and in intervention group monitol is injected then we measure its effect on reducing pain and improving patient function
Participants/Inclusion and exclusion criteria
Inclusion criteria :age : 38 to75 years old
Gender: male or female
Knee radiography anterior standing view have been for the last one month
Have symptoms of osteoarthritis include pain, crepitation and knee joint dryness for at least a month without any extra articular involvement .Any injection of the knee joint during the last three of months
Exclusion criteria: sensitivity reaction to test drug
The patient have done total knee arthroplasty
The patient have diseases mimicking the symptoms of knee pain such as neuropathy and radiculopathy
Diseases such as rheumatoid arthritis, Reiter's syndrom, gout
Uncontrolled diabetes,HBA1c more than7.5, BMI more than 40
History of knee trauma,fracture
Patient's mental disorder
Intervention groups
Intervention group:group that receive knee intra articular injection of mannitol
control group: group that receive knee intra articular injection of hypertonic Dextrose.
Main outcome variables
pain, Activity of daily living
General information
Reason for update
misspelling
Acronym
IRCT registration information
IRCT registration number:IRCT20190912044756N1
Registration date:2020-08-24, 1399/06/03
Registration timing:registered_while_recruiting
Last update:2021-12-07, 1400/09/16
Update count:2
Registration date
2020-08-24, 1399/06/03
Registrant information
Name
Nasrin Barzegar
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 71 3648 6787
Email address
dr.nasrin.barzegar1975@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2020-05-20, 1399/02/31
Expected recruitment end date
2020-12-20, 1399/09/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of efficacy of intra articular injection of mannitol versus hypertonic dextrose prolotherapy on decreasing pain and improvement of functions in patients with knee osteoarthritis
Public title
Evaluation of efficacy of intra articular injection of mannitol in patient with knee osteoarthritis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age: 38 to70 years old
Gender: male or female
Knee radiography anterior standing view have been for the last three month
Have symptoms of osteoartritis include pain, crepitation for at least a month without any extra articular involvment
Exclusion criteria:
Any injection of the knee joint during the last three of months
sensitivity reaction to test drug
The patient have done total knee arthroplasty
The patient have diseases mimicking the symptoms of knee pain such as neuropathy and radiculopathy
Diseases such as rheumatoid arthritis, Reiter's syndrom, gout
Uncontrolled diabetes,HBA1c more than7.5, BMI more than 40
History of knee trauma,fracture
Patient's mental disorder
Age
From 38 years old to 75 years old
Gender
Both
Phase
3
Groups that have been masked
Participant
Investigator
Sample size
Target sample size:
60
More than 1 sample in each individual
Number of samples in each individual:
2
If both knee are involve,one kneeis in the intervention group and the other is in the control group
Randomization (investigator's opinion)
Randomized
Randomization description
Complete randomize block design with SSPP software is used for randomization and then sealed non-transparent envelopes are used to hide the random sequence
Blinding (investigator's opinion)
Double blinded
Blinding description
Participant: The participant is explained that if they are interested, they can
join our research project. two methods used to reduce patient pain input study are explained to the patient. Benefits and possible complications of both methods are described to the patient and the patient is told to randomly fall into one of the intervention groups. If the patient is accepted to admit the study, by random allocation soft ware, the patient falls in to one of two groups.
Clinical car giver: we teach the caregiver how to complete the questionnaier. This person is not aware of receiving patient intervention.
Researcher: In this study does not have the ability to blind the reseacher because the researcher performs both intervention himself and is aware of receiving each intervention in the group.
The outcome assessor of the complete questionnaires is given to person who is not aware of the interventions performed and he/she is asked to determine the level of performance in each person according to the questionnaires.
Date analyzer: questionnaire are finally given to a person to review the information. This person doesn't know any of the steps of the work, how to classify and the intervention performed.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Shiraz School of Medicin
Street address
No.11, Ansar Ave., Koohbor Blvd., Zerehi
City
Shiraz
Province
Fars
Postal code
7184747811
Approval date
2019-07-28, 1398/05/06
Ethics committee reference number
IR.SUMS.MED.REC.1398.314
Health conditions studied
1
Description of health condition studied
Osteoarthritis of knee
ICD-10 code
M17
ICD-10 code description
Osteoarthritis of knee
Primary outcomes
1
Description
knee pain
Timepoint
Two weeks ,foure weeks, eight weeks
Method of measurement
Visual Analogue Scale
Secondary outcomes
1
Description
Function of patient
Timepoint
two weeks, four weeks, eight weeks
Method of measurement
Oxford knee score
Intervention groups
1
Description
Intervention group: the group that receive 5cc mannitol, knee intra articular injection ,in three doses as the first dose and two weeks, four weeks , weeks after first dose and control group that receive 5cc of dextrose 25%,inter articular injection,as sequence of intervention group.
Category
Rehabilitation
2
Description
Control group: group who received knee intra articular injection of hypertonic dextrose
Category
Rehabilitation
Recruitment centers
1
Recruitment center
Name of recruitment center
Emam reza rehabilitation clinic
Full name of responsible person
Mani Ramzi
Street address
Namazi square
City
Shiraz
Province
Fars
Postal code
714737-71348
Phone
+98 71 3212 7000
Email
motahari@sums.ac.ir
Web page address
2
Recruitment center
Name of recruitment center
Rajaee haspital
Full name of responsible person
Amir Reza mesbahi
Street address
Chamran Blvd
City
Shiraz
Province
Fars
Postal code
7194815711
Phone
+98 71 3636 4001
Fax
Email
Rajaeehospital@sums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Dr ghasemi
Street address
Khalili Aveno,front of maaref school
City
Shiraz
Province
Fars
Postal code
7134814336
Phone
+98 71 3628 1506
Email
Info@sums.ac.i
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shiraz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nasrin barzegar
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
No.11 , Ansar Ave., koohbor Blvd., Zerehi
City
Shiraz
Province
Fars
Postal code
7184747811
Phone
+98 71 3648 6787
Email
Dr.nasrin.barzegar1975@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nasrin barzegar
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
No.11., Ansar Avn., koohbor Blvd., Zerehi
City
Shiraz
Province
Fars
Postal code
7184747811
Phone
00986486787
Email
Dr.nasrin.barzegar1975@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nasrin barzegar
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
No11., AnsarAve ., koohbor Blvd., Zerehi
City
Shiraz
Province
Fars
Postal code
7184747811
Phone
+98 71 3648 6787
Email
Dr.nasrin.barzegar1975@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All available data can be shared after making people unidentifiable.
When the data will become available and for how long
Start access period one year after publishing the results.
To whom data/document is available
everyone can access to this information.
Under which criteria data/document could be used
if the information in this study helps to improve the science process.
From where data/document is obtainable
dr.nasrin.barzegar1975@gmail.com 00989173092357
What processes are involved for a request to access data/document
After sending the desired message, all authors of the study will be consulted all information will be sent within a maximum of three weeks if permitted.